Virtu KCG Holdings’s Biostage, Inc. Common Stock BSTG Stock Holding History

Virtu KCG Holdings’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4K	Sell	10,267 -15,199	-60%	-$4.83K	﹤0.01%	2810
2017 Q1	$9K	Buy	25,466 +8,414	+49%	+$4.61K	﹤0.01%	3028
2016 Q4	$15K	Buy	+17,052	New	+$15.2K	﹤0.01%	3262
2016 Q3	–	Sell	-11,974	Closed	-$14K	–	3723
2016 Q2	$14K	Sell	11,974 -1,322	-10%	-$2.13K	﹤0.01%	2830
2016 Q1	$24K	Sell	13,296 -3,965	-23%	-$6.58K	﹤0.01%	2576
2015 Q4	$38K	Sell	17,261 -5,937	-26%	-$8.27K	﹤0.01%	3207
2015 Q3	$20K	Buy	23,198 +9,027	+64%	+$10.2K	﹤0.01%	3162
2015 Q2	$20K	Buy	+14,171	New	+$34.7K	﹤0.01%	3187
2015 Q1	–	Sell	-13,109	Closed	-$42K	–	4242
2014 Q4	$42K	Buy	+13,109	New	+$64.9K	﹤0.01%	3486

Other funds holding BSTG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's BSTG Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Biostage, Inc. Common Stock (BSTG) stake by 60% in Q2 2017, selling an estimated $4.83K and leaving 10,267 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

Virtu KCG Holdings first reported a position in BSTG in Q4 2014 and has held it in 9 quarters since. The position peaked at $42K in Q4 2014. 24 funds tracked by Wall St. Rank hold BSTG as of Q2 2017.

Virtu KCG Holdings held 10,267 shares of Biostage, Inc. Common Stock worth $4K as of Q2 2017.
Virtu KCG Holdings sold 15,199 Biostage, Inc. Common Stock shares in Q2 2017, an estimated $4.83K.
Biostage, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2810 holding.
Virtu KCG Holdings first reported a position in Biostage, Inc. Common Stock in Q4 2014 and has held it in 9 quarters since.
Virtu KCG Holdings's Biostage, Inc. Common Stock position peaked at $42K in Q4 2014.
24 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.